Professional Documents
Culture Documents
Myeloproliferative Malignant
diseases Leukaemias lymphomas
hairy cell
leukaemia
(HCL)
Haematopoietic Malignancies
Myeloproliferative Malignant
Leukaemias
diseases lymphomas
Family of chronic Neoplastic Neoplastic
neoplastic disease of a disease of
diseases haematopoietic lymphatic tissue
precursor cell
Due to a clonal Originates in
disorder arising Characterised by lymph node or
at the level of the replacement of spleen
pluripotent stem normal bone
Hodgkin’s (15%)
cell marrow
Characterised by Often infiltration non-Hodgkin’s
abnormal into other organs (85%)
proliferation of 1
Malignant clones
or more blood cell
lines suppress normal
cell formation
The Lymphatic
System
Lymphatic Tissue
o rtex
c
x follicle (mainly B-
c ort e cells)
a
par - germinal centre
dulla - mantle zone
me
artery
85% of lymphomas
6th major cause of cancer deaths yearly
Heterogeneous group of malignant diseases
arising from lymphoid tissue
– lymph nodes, spleen
Various immune cell types
– principally B-cells derivation (>85%)
– T-cells derivation
– Histiocytes (very rarely)
– Various stages of differentiation and maturation
NHL Incidence
North America
South Central Asia
Eastern Europe
Southeast Asia
Northern Europe
Western Africa
Northern Africa
Australia/New Zealand
Caribbean
Melanesia
Micronesia
60,000
Estimated Annual Incidence
45,000
30,000
~4% compound annual
increase in incidence
15,000
0
1980 1985 1990 1995 2000
Year
% of NHL Median
Class Patients Survival (y)
A. Small lymphocytic 3.6 5.8
B. Follicular, predominantly
small cleaved cell 22.5 7.2
100 1987-1996
1976-1986
80 1960-1975
Patients (%)
60
40
20
0
0 5 10 15 20 25 30
Year
79%
75
Overall survival (%)
69%
50
25
0 Adapted from
1974-1978 1988-1994 1998-2000 ref 1
CHOP + ProMACE – MOPP CHOP + monoclonal
non-specific + Interferon antibody therapy
immunostimulants
100
Overall Survival (%)
80
IPI 0/1
60
IPI 2/3
40
20
P<0.001 IPI 4/5
0
0 1 2 3 4 5 6 7 8
Year
100
CHOP
m-BACOD
80 ProMACE-CytaBOM
MACOP-B
Patients (%)
60
40
20
0
0 1 2 3 4 5 6
Risk
Risk Group Factors
All ages Low (L) 0-1
Low-intermediate (LI) 2
High-intermediate (HI) 3
High (H) 4-5
Age-adjusted L 0
LI 1
HI 2
H 3
100
75
Patients (%)
L
50
LI
HI
25
0
0 2 4 6 8 10
Year
100
75 L
Patients (%)
LI
50
HI
25 H
0
0 2 4 6 8 10
Year
100
80
Patients (%)
IPI 0-1
60
40
IPI 2-3
20 IPI 4-5
P<0.001
0
0 1 2 3 4 5 6 7 8
Year